IXJ

iShares Global Healthcare ETF

Medical groups and more than 1,000 health officials have urged Robert F. Kennedy Jr. to resign, warning his vaccine policies are putting public health at risk.

The administration is expected to release findings from a separate semiconductor investigation first, with other high-profile events also contributing to the delay.

Several drugmakers, including AstraZeneca and Eli Lilly, have already pledged major investments in U.S. manufacturing.

The U.S. health department is canceling or scaling back 22 BARDA-backed mRNA projects worth nearly $500 million, shifting funding toward broader vaccine platforms.

The letters laid out specific demands, including matching the lowest global prices for Medicaid patients and ending preferential pricing abroad, while warning that failure to comply would trigger federal action.

The Trump administration is reportedly considering a major restructuring of the FDA’s biologics division, potentially splitting it into separate offices for vaccines and therapeutics.

Federal health officials are reportedly already vetting new members for the task force, with discussions suggesting a shift away from its current physician-heavy makeup.

Investing.com -- Clients of Bank of America Securities turned net sellers of U.S. equities last week, marking the first weekly outflow in five weeks as the S&P 500 dropped 2.6%.